Aphex Pharma SolutionsAphex Pharma Solutions
Aphex Pharma Solutions
Home
About Us
Events
PDC 2026
Past PDCs
Contact Us
Aphex Pharma SolutionsAphex Pharma Solutions

Your partner in Pharmaceutical Quality, CMC and Regulatory Solutions

    ABOUT US

    Home
    About Us
    Event Bookings
    Contact

    SERVICES

    Quality Management
    CMC Advisory
    CMC Regulatory
    Drug Discovery
    Training
    Recruitment

    RESOURCES

    PDC
    Past PDCs
    Become a PDC 2026 Sponsor
    Terms of Service
Copyright © 2026 Aphex Pharma SolutionsABN 93 666 546 845Admin
Website designed and maintained by Webifex Labs
Conference Agenda 2026

Aphex Pharma Solutions

HomePDC 2026Conference Agenda 2026

Conference Agenda 2026

Register for PDC 2026
8:00 am

Registration and Networking

8:45 am

Welcome and Opening Remarks

Ahsan Syed Ali

Managing Director

Aphex Pharma Solutions

Welcome to PDC 2026

9:00 am

Keynote Presentation

Dr. Rebecca Tunstall

Chief Operating Officer

Prescient Therapeutics

Building the Development Engine: From Bench to Phase 2 and Beyond - Bringing a First-in-Class Therapy to Patients

9:30 am

Company Story and Product Development Updates

Dr. Tracey Brown

Chief Executive Officer

GAIASO Theranostics

GAIASO Technology Development Approach and Plans

9:40 am

Company Story And Product Development Update

Dr. Eliana Mariño

CEO & Founder

ImmunoBiota Therapeutics Pty Ltd

Company Story And Product Development Update

9:50 am

Company Story and Product Development Updates

Leopoldt de Bruin

CEO and Managing Director

ESN Cleer

Product Development Update

10:00 am

Company Story and Product Development Updates

Dr. Sarika Namjoshi

Chief Operating Officer

Tissue Repair Ltd

Product Development Update

10:10 am

Presentation

Penelope Lane

Chief Executive Officer & Managing Director

MLS Bio

Product Development Update

10:20 am

Unlocking Non-Dilutive Capital: Funding Strategies for Growth

Stuart Haines

Founder and CEO

Haines Consulting Group

Unlocking Non-Dilutive Capital: Funding Strategies for Growth

10:30 am

Morning Tea and Networking Break

11:00 am
Pre-Clinical & Clinical Development
Room 1 - Octagonal
Dr. Rebbecca Wilcox

CEO and Principal Consultant

Minotaur Pharma Pty Ltd

Starting with the End in Mind: Designing Nonclinical Strategy to Support Global Clinical Expansion

Formulation & Manufacturing Development
Room 2 - Estate Vineyard
Dr. Michael Andrews Luke

CEO & Managing Director

Formulytica

From Formulation to Clinic: Translating Innovation into Development-Ready Medicines

11:30 am
Pre-Clinical & Clinical Development
Room 1 - Octagonal
Dr. Jason Wang

Site Head

Resolian

Bioanalysis of Biosimilar

Formulation & Manufacturing Development
Room 2 - Estate Vineyard
Vanessa Zann

VP Scientific Consulting, TP-CP USA

Quotient Sciences

Use of Quotient’s Platform “Translational Pharmaceutics” for Solubility Enhancement, Modified Release and Oral Peptide Formulations

12:00 pm
Pre-Clinical & Clinical Development
Room 1 - Octagonal
Greg Plunkett

CEO and Managing Director

Accelagen

Formulation & Manufacturing Development
Room 2 - Estate Vineyard
Justine Mann

Chief Executive Officer

Pure Solutions Australia Pty Ltd

Trial Success Through Robust Sterile Drug Product Manufacturing

12:30 pm

Lunch and Networking Break

1:30 pm
Pre-Clinical & Clinical Development
Room 1 - Octagonal
William Reece

Director, Biostatistics

Fortrea

Early Phase Oncology Design in Light of Project Optimus

Formulation & Manufacturing Development
Room 2 - Estate Vineyard
Dr. Garima Sharma

Senior Research Scientist

Medicines Manufacturing Innovation Centre (MMIC)

Formulation Development for Preclinical Programs: Lessons from the Bench

2:00 pm
Pre-Clinical & Clinical Development
Room 1 - Octagonal
Matthew Bugg

Global Quality Director

MaHPharma Pty Ltd

Formulation & Manufacturing Development
Room 2 - Estate Vineyard
Dr. Hongyi Ouyang

Regional Technical Sales Manager - Pharmaceuticals

Gattefosse

Enhancing Oral Bioavailability with Functional Lipid Excipients

2:30 pm
Pre-Clinical & Clinical Development
Room 1 - Octagonal
PDCComing Soon
Formulation & Manufacturing Development
Room 2 - Estate Vineyard
Dr. Maiada Sadek

CMC Consultant

Aphex Pharma Solutions

Navigating Simple and Complex CMC Programs Across Development Lifecycle: Overcoming Key Challenges

3:00 pm

Afternoon Tea and Networking Break

3:30 pm
Pre-Clinical & Clinical Development
Room 1 - Octagonal
PDCComing Soon
Formulation & Manufacturing Development
Room 2 - Estate Vineyard
Ana Benatti

Head of Quality and Regulatory Affairs

QBiotics

4:00 pm

Plenary Session

Ahsan Syed Ali

Managing Director

Aphex Pharma Solutions

Building Scalable and Phase Appropriate CMC and Quality Resourcing

Dr. Maiada Sadek

CMC Consultant

Aphex Pharma Solutions

Adriana Terreros

Quality Consultant

Aphex Pharma Solutions

4:30 pm

Panel Discussion, Q&A and Closing Comments

5:00 pm

Networking Session (RSVP Only)

Want to Present at PDC 2026?

We're looking for industry experts to share their insights and experiences. Contact us to submit your presentation proposal.

Submit ProposalBack to PDC 2026

For updates on the full agenda and speaker lineup, please contact us or check back soon.